Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free TLSIW Stock Alerts

TriSalus Life Sciences (TLSIW) Competitors

TriSalus Life Sciences logo
$0.52 -0.09 (-14.12%)
Closing price 06/8/2026 03:51 PM Eastern
Extended Trading
$0.52 +0.00 (+0.77%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

TLSIW vs. DRTSW, ANZUW, CNXU, HSCSW, and BEATW

Should you buy TriSalus Life Sciences stock or one of its competitors? MarketBeat compares TriSalus Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TriSalus Life Sciences include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Conexeu Sciences (CNXU), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). These companies are all part of the "medical equipment" industry.

How does TriSalus Life Sciences compare to Alpha Tau Medical?

TriSalus Life Sciences (NASDAQ:TLSIW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, TriSalus Life Sciences' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Alpha Tau Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Anzu Special Acquisition Corp I?

TriSalus Life Sciences (NASDAQ:TLSIW) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

In the previous week, TriSalus Life Sciences' average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Anzu Special Acquisition Corp I Neutral

Summary

TriSalus Life Sciences beats Anzu Special Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Conexeu Sciences?

TriSalus Life Sciences (NASDAQ:TLSIW) and Conexeu Sciences (NASDAQ:CNXU) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Conexeu Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Conexeu SciencesN/AN/AN/AN/AN/A

In the previous week, Conexeu Sciences had 4 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 4 mentions for Conexeu Sciences and 0 mentions for TriSalus Life Sciences. Conexeu Sciences' average media sentiment score of 0.46 beat TriSalus Life Sciences' score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Conexeu Sciences Neutral

Summary

Conexeu Sciences beats TriSalus Life Sciences on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Heart Test Laboratories?

TriSalus Life Sciences (NASDAQ:TLSIW) and Heart Test Laboratories (NASDAQ:HSCSW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Heart Test Laboratories$8.67KN/AN/AN/AN/A

In the previous week, TriSalus Life Sciences' average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Heart Test Laboratories Neutral

Summary

TriSalus Life Sciences beats Heart Test Laboratories on 1 of the 1 factors compared between the two stocks.

How does TriSalus Life Sciences compare to HeartBeam?

TriSalus Life Sciences (NASDAQ:TLSIW) and HeartBeam (NASDAQ:BEATW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

In the previous week, TriSalus Life Sciences' average media sentiment score of 0.00 equaled HeartBeam'saverage media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
HeartBeam Neutral

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
HeartBeam N/A N/A N/A

Summary

TriSalus Life Sciences beats HeartBeam on 1 of the 1 factors compared between the two stocks.

Get TriSalus Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLSIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLSIW vs. The Competition

Export
MetricTriSalus Life SciencesMedical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.11B$6.47B$11.98B
Dividend YieldN/A2.66%2.67%5.58%
P/E RatioN/A14.3423.6923.74
Price / SalesN/A126.34533.79119.57
Price / CashN/A15.9926.9937.25
Price / BookN/A4.4810.366.78
Net IncomeN/A$144.75M$3.57B$337.51M
7 Day Performance-5.45%-1.26%0.27%-2.34%
1 Month Performance-48.00%-2.98%3.26%1.88%
1 Year Performance-66.88%-1.46%22.22%25.55%

TriSalus Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLSIW
TriSalus Life Sciences
N/A$0.52
-14.1%		N/A-66.9%$0.00$44.88MN/A106
DRTSW
Alpha Tau Medical
N/A$2.54
-0.8%		N/A+805.0%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.06
flat		N/A-9.1%$0.00N/AN/A2
CNXU
Conexeu Sciences
N/A$13.63
-1.0%		N/AN/A$0.00N/AN/A4
HSCSW
Heart Test Laboratories
N/A$0.05
-5.1%		N/A+13.6%$0.00$8.67KN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:TLSIW) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel